MacroGenics | MGNX - Trade Creditors


MacroGenics reported $5.94M in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
AbbVie USD 3.59B 28.65B Dec/2025
Amgen USD 20.89B 1.25B Dec/2025
AstraZeneca USD 25.28B 252M Dec/2025
Biogen USD 432M 18.9M Dec/2025
Bristol-Myers Squibb USD 4.29B 1.14B Sep/2025
Daiichi Sankyo JPY 568.5B 16.84B Dec/2025
Eli Lilly USD 5.38B 1.12B Dec/2025
Genmab DKK 6M 2M Sep/2025
Geron USD 11.11M 2.88M Sep/2025
Gilead Sciences USD 808M 226M Sep/2025
J&J USD 11.99B 2.37B Dec/2025
Karyopharm Therapeutics USD 5.39M 2.8M Sep/2025
MacroGenics USD 5.94M 1.28M Sep/2025
Merck USD 4.15B 102M Sep/2025
Pfizer USD 5.02B 142M Sep/2025
Puma Biotechnology USD 6.39M 962K Sep/2025
Regeneron Pharmaceuticals USD 5.83B 4.93B Dec/2025
Roche Holding CHF 5.78B 1.27B Dec/2025
Xencor USD 10.83M 1.75M Dec/2025